Hot-Topics Cell-Gene-Therapies 
pharmaphorum
NOVEMBER 15, 2022
The day will continue with other hot topics for pharma, including health equity, cell and gene therapy, oncology, and pharmacy model disruption. Then we’ll hear from Aptar Digital Health’s Sai Shankar and Pierre Laurent in a session all about patients as partners in healthcare.
pharmaphorum
JANUARY 13, 2022
AstraZeneca has expanded its efforts to develop new therapies targeting transcription factors – proteins that regulate processes in the cell that have become a hot topic for drug discovery in cancer and other diseases.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
MARCH 19, 2021
The company has developed a toolkit called Site-Directed Enzyme Enhancement Therapy or SEE-Tx, which uses computational techniques to find small-molecule drugs that are able to bind to sites on misfolded proteins, restore their shape and function and in some cases prevent them clumping together.
ISPE
MARCH 8, 2023
Rachel is excited about hot topics and potential task teams being discussed within IPNA-EU CoP, including cell and gene therapy. Cell and gene therapy is moving us toward more and more personalized medicine, which isn’t a new concept, but it is becoming more of a reality.
ISPE
JULY 20, 2023
This year the problem statement was set by our hackathon sponsor, Roche, and it focused on the hot topic of ATMPs (Advanced Therapy Medicinal Products - also known as Cell & Gene Therapy in the USA).
pharmaphorum
APRIL 20, 2022
The potential of CRISPR technology has been a hot topic in the industry ever since it was first developed, but as trials progress further into the clinic, what therapeutic areas could be set to benefit? coli, and their research in turn formed the foundation for the CRISPR-based therapies being explored to create new treatment options.
The FDA Law Blog
OCTOBER 6, 2022
Lewis, Senior Regulatory Device & Biologics Expert — On September 29, 2022, FDA’s Center for Biologics Evaluation and Research (CBER) and the Office of Tissues and Advanced Therapies (OTAT) held a town hall to answer questions related to gene therapy chemistry, manufacturing, and controls. Depending on the change (e.g.,
Expert insights. Personalized for you.
113 
Let's personalize your content